Ignasi Canals Almazán

Chief Scientific Officer (CSO) at OXOLIFE

Ignasi Canals Almazán has a diverse work experience in the field of scientific research and medical affairs.

From 2013 to present, they have been working at OXOLIFE, initially as the CEO/CSO and currently as the Chief Scientific Officer (CSO). Their responsibilities at OXOLIFE include scientific tasks such as designing and developing research plans, analyzing results, and evaluating new research lines or alliances. Ignasi is also involved in "start-up" operations, including business development, partnering and funding, and designing business plans.

In 2015, Ignasi Canals Almazán worked as a Freelancer, although no specific details about the role are provided.

Prior to that, they worked at Bayer Pharmaceuticals from 2007 to 2018. Ignasi held various positions in the company, including Medical Scientific Liaison in the Cardiovascular therapeutic area and later in the Women's Health area. In these roles, they were responsible for planning and managing medical projects with key opinion leaders (KOLs) and medical societies. Ignasi also designed and performed medical plans, managed medical information, conducted clinical trials, and oversaw team management.

Before joining Bayer Pharmaceuticals, Ignasi Canals Almazán worked as an Independent Researcher in the field of fertility from 2010 to 2013. Ignasi also served as a Ph Doctoral Fellow at Universitat de Barcelona from 2002 to 2007.

Overall, Ignasi Canals Almazán has extensive experience in scientific research, medical affairs, and "start-up" operations, with a particular focus on reproductive efficiency and fertility.

Ignasi Canals Almazán completed their education in the field of Biochemistry. Ignasi earned a PhD in Biochemistry from an unspecified institution, with a duration of five years from 2002 to 2007. Prior to that, they pursued a Licenciatura degree in Bioquímica at the Universitat Autònoma de Barcelona, spanning six years from 1995 to 2001. Additionally, Ignasi Canals Almazán obtained a certification as "Col·legiat 21430-C" from the Col·legi de Biòlegs de Catalunya, although the specific details regarding the institution and year of completion are not provided. There is also mention of a school called "Purificació Salas", but no information is given about the degree or field of study pursued at this institution.

Links

Previous companies

Bayer logo

Timeline

  • Chief Scientific Officer (CSO)

    September, 2019 - present

  • CEO/CSO

    January, 2013